Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Rosetta Genomics has successfully completed the acquisition of Parkway Clinical Laboratories, a privately-held company owning a CLIA-certified lab located in Bensalem, Pennsylvania.
Subscribe to our email newsletter
The company has acquired Parkway for an aggregate purchase price of $2.9 million, consisting of $1.9 million in cash and $1 million of Rosetta’s ordinary shares. An additional $300,000 will be payable upon the achievement of certain milestones.
The acquisition is expected to allow Rosetta Genomics to expedite development and validation of its microRNA-based diagnostic tests both in the US and worldwide. In addition, ownership of the CLIA-certified lab will allow Rosetta Genomics to control the commercialization of its diagnostics, including marketing, sales, and reimbursement strategy.